| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |